MedTrace Logo

Prospective Electroencephalography Evaluation of Sedation in COVID-19

NCT04815109 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-08-05

No results posted yet for this study

Summary

Sedation of severe COVID-19 disease are often complicated. We try to find a correlate for this observation by encephalographic studies.

Conditions

  • Conscious Sedation
  • Pathologic Processes
  • Electroencephalogram
  • Acute Respiratory Distress Syndrome
  • Corona Virus Infection

Interventions

OTHER

Encephalography measurement

Encephalography measurement and partially aggravated sedation.

Sponsors & Collaborators

  • Goethe University

    lead OTHER

Principal Investigators

  • Armin N Flinspach, M.D. · Goethe-University Frankfurt

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2022-02-28
Completion
2022-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04815109 on ClinicalTrials.gov